ArticleJournal of experimental & clinical cancer research : CR2024

Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy.

Lauretta Levati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.